Mothaffar F. Rimawi

Mothaffar F. Rimawi, F.A.C.P.

Picture

Mothaffar F. Rimawi, F.A.C.P.

Professor

Phone

832-957-6500

Request Clinical Appointment

Email

rimawi@bcm.edu

Positions

Professor: Department of Medicine
Section of Hematology and Oncology
Baylor College of Medicine
Houston, Texas United States

Executive Medical Director: Dan L Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, Texas United States

Associate Director for Clinical Affairs: Dan L Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, Texas United States

Philip A. Salem, M.D. Chair in Cancer Research: Baylor St. Luke's Medical Center
Houston, Texas United States

Addresses

Dan L Duncan Comprehensive Cancer Center (Clinic)
: Dan L Duncan Comprehensive Cancer Center
1919 Old Spanish Trail
Houston, TX 77054
United States
Phone: (832) 957-6500
Fax: (713) 610-4595
rimawi@bcm.edu

McNair Campus (Office)
: Dan L Duncan Comprehensive Cancer Center
1919 Old Spanish Trail
Houston, TX 77054
United States
Phone: (713) 798-1311
rimawi@bcm.edu

Education

MD from University Of Jordan: 06/1997 - Amman, Jordan

Residency at Baylor College Of Medicine: 08/2001 - Houston, Texas United States; Internal Medicine

Fellowship at Baylor College Of Medicine: 11/2004 - Houston, Texas United States; Medical Oncology and Hematology

Fellowship at Baylor College Of Medicine: 05/2005 - Houston, Texas United States; Breast Cancer

Certifications

Board Certified-Medical Oncology: (11/01/2014); American Board of Internal Medicine

Board Certified-Internal Medicine: (12/29/2011); American Board of Internal Medicine

Professional Interests

Management of Breast Cancer
Clinical Trials in Breast Cancer
Neoadjuvant Therapy
Targeted therapy and Biomarkers in Breast Cancer.
HER2-positive Breast Cancer
Locally advanced breast cancer
Treatment Resistance

Professional Statement

I am a board certified medical oncologist specializing in breast cancer care and research. I am the Executive Medical Director of the Dan L Duncan Comprehensive Cancer Center.
My research is focused on translating laboratory findings to the clinic to develop new treatments for breast cancer, and then taking clinical findings and materials back to the lab to study them with other scientists. Related to that, my team’s work has been pivotal in treatment optimization for HER2+ Breast Cancer, endocrine therapy for ER+ Breast Cancer, and new targeted therapy for Triple Negative Breast Cancer.
I dream of a world free of the pain and suffering of breast cancer and work tirelessly every day towards making that dream a reality.